Skip to content

Clinical trials

Completed Phase 1/2 Respiratory Distress Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 1/2 Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20061
20091
20111
20121
20151
20161
20171
20191
202012
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Apellis Pharmaceuticals, Inc.1
Assistance Publique - Hôpitaux de Paris1
Banc de Sang i Teixits1
Baylor College of Medicine1
Camillo Ricordi1
Eli Lilly and Company1
FDA Office of Orphan Products Development1
Faron Pharmaceuticals Ltd1
Healios K.K.1
Histocell, S.L.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome25
COVID-1913
Acute Lung Injury6
Coronavirus Infections4
Pneumonia2
Sepsis2
Severe Acute Respiratory Syndrome2
Bronchiolitis Obliterans1
Hypoxia1
Influenza, Human1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.